Early and late outcomes of bevacizumab plus chemotherapy versus chemotherapy alone as a neoadjuvant treatment in HER2-negative nonmetastatic breast cancer: a meta-analysis of randomized controlled trials - Wei, Jinli; Luo, Yulin; Fu, Deyuan (OncoTargets and therapy, 2018)
Keywords: Adjuvant chemotherapy; Analysis; Antineoplastic agents; Bevacizumab; Bias; Breast cancer; Cancer therapies; Cancer treatment; Carboplatin; Care and treatment; Chemotherapy; Clinical trials; ErbB-2 protein; Hormones; Immunotherapy; Mastectomy; Meta-analysis; Metastasis; Monoclonal antibodies; Patient outcomes; Review; Studies; Survival; Systematic review; Targeted cancer therapy; bevacizumab; neoadjuvant chemotherapy; breast cancer; HER2-negative; randomized controlled trial